naltrexone has been researched along with butorphanol in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (10.87) | 18.7374 |
1990's | 17 (36.96) | 18.2507 |
2000's | 13 (28.26) | 29.6817 |
2010's | 8 (17.39) | 24.3611 |
2020's | 3 (6.52) | 2.80 |
Authors | Studies |
---|---|
Bousquet, AR; Howes, JF; Kotick, MP; Polazzi, JO | 1 |
Bousquet, AR; Howes, JF; Kotick, MP; Leland, DL; Polazzi, JO | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bidlack, JM; Bu, Y; Cohen, DJ; Lou, R; Lu, Q; VanAlstine, MA; Wentland, MP | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M; Oh, KW | 2 |
Dykstra, LA | 1 |
Cho, TM; Nozaki, M | 1 |
Hynes, MD; Leander, JD; Reel, JK; Zimmerman, DM | 1 |
Hameroff, SR | 1 |
Billington, CJ; Grace, M; Levine, AS; Portoghese, PS | 1 |
Amundsen, L; Binstock, W; Cox, SM; Faure, EA; Glosten, B; Hibbard, J; Ismail, M; Moawad, AH; Senal, JA; Wittels, B | 1 |
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M | 1 |
Ho, IK; Hoskins, B; Jaw, SP | 2 |
Brandt, MR; France, CP | 1 |
Feng, YZ; Ho, IK; Rockhold, RW; Tokuyama, S; Zhang, T; Zhu, H | 1 |
Ho, IK; Hoshi, K; Ma, T; Oh, S | 1 |
Barton, C; Bray, GA; Ookuma, K; York, DA | 1 |
Burke, TF; Garner, HR; Lawhorn, CD; Stoner, JM; Wessinger, WD | 1 |
Feng, Y; Ho, IK; Rockhold, RW | 1 |
He, Z; Ho, IK; Tsang, BK; Wongchanapai, W | 1 |
Butelman, ER; Ko, MC; Mosberg, HI; Sobczyk-Kojiro, K; Van Bemmel, B; Woods, JH; Zernig, G | 1 |
Morgan, D; Picker, MJ | 1 |
Aguilar, R; Bailey, JE; Foerster, CR; Foerster, SH; Loria, DL | 1 |
Childs, SE; Ferrell, ST; Radcliffe, RW | 1 |
Hendrickson, DA; Radcliffe, RM; Radcliffe, RW; Richardson, GL; Zuba, JR | 1 |
Billington, CJ; Grace, MK; Jewett, DC; Jones, RM; Levine, AS; Portoghese, PS | 1 |
Ho, IK; Rockhold, RW; Sinchaisuk, S | 1 |
David Clark, J; Demirci, H; Gharagozlou, P; Lameh, J | 1 |
Craft, RM; McNiel, DM | 1 |
Fan, LW; Ho, IK; Ma, T; Park, Y; Rockhold, RW; Sasaki, K; Tanaka, S; Tien, LT | 1 |
Spelman, LH | 1 |
Bigelow, GE; Chausmer, AE; Strain, EC; Walsh, SL | 1 |
Calle, PP; Georoff, TA; James, SB; Kalk, P; Martin-Flores, M | 1 |
Li, M; McMillan, DE; Wessinger, WD | 1 |
Anisimova, VA; Grechko, OIu; Spasov, AA | 1 |
Anisimova, VA; Grechko, OIu; Shtareva, DM; Spasov, AA | 1 |
Hayek, LC; Marker, L; Murray, S; Sanchez, CR; Woc Colburn, AM | 1 |
Balhara, YPS; Gupta, R; Sarkar, S; Shah, B | 1 |
Fisher, MC; Mays, T; Miller, MW; Wolfe, LL | 1 |
Gardner, BR; Kotze, PGH; McCue, SA; Musson, M; Seakamela, SM; Spolander, B | 1 |
Anderson, NE; Delnatte, P; Dutton, C; Ferro, A; Larouche, CB; Milnes, EL; Skelding, AM | 1 |
2 review(s) available for naltrexone and butorphanol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
Topics: Analgesics, Opioid; Buprenorphine; Butorphanol; Endorphins; Humans; Nalbuphine; Nalorphine; Naloxone; Naltrexone; Narcotic Antagonists; Pentazocine; Receptors, Opioid | 1983 |
5 trial(s) available for naltrexone and butorphanol
Article | Year |
---|---|
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Butorphanol; Cesarean Section; Female; Humans; Morphine; Nalbuphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Pregnancy; Prospective Studies | 1993 |
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
Topics: Adult; Affect; Arousal; Butorphanol; Diuresis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Naltrexone; Narcotic Antagonists; Narcotics; Perception; Premedication; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |
Evaluation of medetomidine-ketamine-butorphanol anesthesia with atipamezole-naltrexone antagonism in captive male guanacos (Lama guanicoe).
Topics: Adrenergic alpha-Antagonists; Anesthetics; Animals; Butorphanol; Camelids, New World; Imidazoles; Ketamine; Male; Medetomidine; Naltrexone; Narcotic Antagonists | 2010 |
CARDIORESPIRATORY EFFECTS OF DEXMEDETOMIDINE-BUTORPHANOL-MIDAZOLAM (DBM): A FULLY REVERSIBLE ANESTHETIC PROTOCOL IN CAPTIVE AND SEMI-FREE-RANGING CHEETAHS (ACINONYX JUBATUS).
Topics: Acinonyx; Analgesics, Opioid; Anesthesia; Animals; Animals, Zoo; Butorphanol; Dexmedetomidine; Drug Therapy, Combination; Female; Heart Rate; Hypnotics and Sedatives; Imidazoles; Male; Midazolam; Naltrexone; Respiration | 2017 |
A randomized clinical trial to compare ketamine-butorphanol-azaperone-medetomidine and detomidine-etorphine-acepromazine for anesthesia of captive Przewalski horses (Equus przewalskii).
Topics: Acepromazine; Anesthesia; Animals; Azaperone; Butorphanol; Etorphine; Heart Rate; Horses; Hypnotics and Sedatives; Hypoxia; Imidazoles; Immobilization; Ketamine; Medetomidine; Naltrexone; Oxygen; Prospective Studies | 2022 |
39 other study(ies) available for naltrexone and butorphanol
Article | Year |
---|---|
Analgesic narcotic antagonists. 9. 6-Methylene-8 beta-alkyl-N-(cycloalkylmethyl)-3-hydroxy- or -methoxymorphinans.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Substance Withdrawal Syndrome | 1981 |
Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Codeine; Hydrocodone; In Vitro Techniques; Mice; Narcotic Antagonists; Rats; Reaction Time | 1981 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.
Topics: Amides; Analgesics, Opioid; Humans; Protein Binding; Receptors, Opioid; Structure-Activity Relationship; Tramadol | 2009 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Effects of beta-funaltrexamine on butorphanol dependence.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Butorphanol; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Reinforcement Schedule; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Dose-Response Relationship, Drug; Levallorphan; Male; Methadone; Morphinans; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri | 1990 |
Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor.
Topics: Animals; Butorphanol; Cell Membrane; Dihydromorphine; Diprenorphine; Dithionitrobenzoic Acid; Dithiothreitol; Etorphine; Morphine; Nalorphine; Naloxone; Naltrexone; Nitrobenzoates; Oxymorphone; Rats; Receptors, Opioid | 1985 |
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Biological Assay; Buprenorphine; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Etorphine; Fentanyl; Methadone; Mice; Morphine; Muscle Contraction; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, mu | 1987 |
Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol.
Topics: Animals; Butorphanol; Injections, Intraventricular; Male; Naloxone; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
The effect of selective opioid antagonists on butorphanol-induced feeding.
Topics: Animals; Butorphanol; Dose-Response Relationship, Drug; Feeding Behavior; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Effects of nor-binaltorphimine on butorphanol dependence.
Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1993 |
Opioid antagonists and butorphanol dependence.
Topics: Animals; Behavior, Animal; Butorphanol; Indoles; Injections, Intraventricular; Male; Morphinans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 1993 |
Involvement of delta-opioid receptors in physical dependence on butorphanol.
Topics: Animals; Butorphanol; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substance-Related Disorders | 1993 |
Discriminative stimulus effects on enadoline in pigeons.
Topics: Animals; Benzofurans; Butorphanol; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Dynorphins; Nalbuphine; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa | 1996 |
Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
Topics: Animals; Butorphanol; Drug Evaluation, Preclinical; Injections, Intraventricular; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin; Substance Withdrawal Syndrome | 1996 |
Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
Topics: Animals; Benzeneacetamides; Butorphanol; Drug Evaluation, Preclinical; Excitatory Amino Acids; Locus Coeruleus; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Effect of enterostatin and kappa-opioids on macronutrient selection and consumption.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Colipases; Dietary Carbohydrates; Dietary Fats; Eating; Enzyme Precursors; Food Preferences; Male; Naltrexone; Narcotic Antagonists; Narcotics; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1997 |
Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Butorphanol; Male; Mice; Morphine; Naltrexone; Pyrrolidines; Receptors, Opioid, mu | 1997 |
Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
Topics: Animals; Butorphanol; Excitatory Amino Acids; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1997 |
Differential involvement of opioid receptors in intrathecal butorphanol-induced analgesia: compared to morphine.
Topics: Analgesics, Opioid; Animals; Butorphanol; Dose-Response Relationship, Drug; Injections, Spinal; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 1998 |
kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.
Topics: Analgesics, Opioid; Animals; Benzofurans; Brain Chemistry; Butorphanol; Dose-Response Relationship, Drug; Hot Temperature; Macaca mulatta; Nalbuphine; Naltrexone; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa | 1998 |
The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
Topics: Animals; Buprenorphine; Butorphanol; Columbidae; Discrimination Learning; Female; Fentanyl; Levallorphan; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu | 1998 |
Butorphanol/xylazine/ketamine immobilization of free-ranging Baird's tapirs in Costa Rica.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Anesthetics, Combined; Anesthetics, Dissociative; Animals; Animals, Wild; Blood Gas Analysis; Blood Pressure; Butorphanol; Costa Rica; Electrocardiography; Female; Heart Rate; Immobilization; Ketamine; Male; Naltrexone; Narcotic Antagonists; Oximetry; Perissodactyla; Respiration; Tolazoline; Xylazine; Yohimbine | 2000 |
Butorphanol and azaperone as a safe alternative for repeated chemical restraint in captive white rhinoceros (Ceratotherium simum).
Topics: Analgesics, Opioid; Anesthetics, Combined; Animals; Azaperone; Butorphanol; Female; Heart Rate; Hypnotics and Sedatives; Immobilization; Injections, Intramuscular; Male; Naltrexone; Oximetry; Perissodactyla | 2000 |
Standing laparoscopic-guided uterine biopsy in a southern white rhinoceros (Ceratotherium simum simum).
Topics: Analgesics, Opioid; Animals; Anti-Infective Agents; Azaperone; Biopsy; Butorphanol; Dinoprost; Dinoprostone; Female; Hypnotics and Sedatives; Hysteroscopy; Laparoscopy; Naltrexone; Perissodactyla; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography; Uterus; Vulva | 2000 |
The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Brain; Butorphanol; Drug Interactions; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Food Deprivation; Guanidines; Male; Morphinans; Naltrexone; Narcotic Antagonists; Narcotics; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2001 |
Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Topics: Animals; Basal Ganglia; Butorphanol; Diffusion; Electric Stimulation; Male; Microinjections; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Stereotaxic Techniques; Stereotyped Behavior; Substance Withdrawal Syndrome | 2002 |
Activity of opioid ligands in cells expressing cloned mu opioid receptors.
Topics: Azocines; beta-Endorphin; Binding, Competitive; Butorphanol; Cell Line; Colforsin; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Etorphine; Fentanyl; Humans; Hydromorphone; Ligands; Morphine; Naltrexone; Phenazocine; Radioligand Assay; Receptors, Opioid, mu; Tritium | 2003 |
Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
Topics: Animals; Benzeneacetamides; Butorphanol; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pentazocine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Urination | 2003 |
Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol.
Topics: Animals; Brain; Butorphanol; Dose-Response Relationship, Drug; Male; Naltrexone; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders | 2003 |
Reversible anesthesia of captive California sea lions (Zalophus californianus) with medetomidine, midazolam, butorphanol, and isoflurane.
Topics: Anesthetics, Combined; Anesthetics, Inhalation; Animals; Antidotes; Butorphanol; Dose-Response Relationship, Drug; Female; Flumazenil; Heart Rate; Hypnotics and Sedatives; Imidazoles; Immobilization; Isoflurane; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists; Narcotics; Respiration; Sea Lions; Time Factors | 2004 |
Drug discrimination in pigeons trained to discriminate among morphine, U50488, a combination of these drugs, and saline.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Ethylketocyclazocine; Male; Morphine; Naltrexone; Narcotic Antagonists; Pentazocine; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reinforcement Schedule; Sodium Chloride | 2011 |
[Model of platelet activation as experimental test system for screening kappa-opioid receptor ligands].
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Benzimidazoles; Blood Platelets; Butorphanol; High-Throughput Screening Assays; Ligands; Light; Naltrexone; Platelet Activation; Rabbits; Receptors, Opioid, kappa; Scattering, Radiation | 2011 |
[Analgesic properties of morpholinoethylimidazobenzimidazole derivative RU-1205].
Topics: Analgesics; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Male; Mice; Morpholines; Naloxone; Naltrexone; Narcotic Antagonists; Nociception; Pain; Pain Measurement; Rats; Receptors, Opioid, kappa | 2013 |
Injection Butorphanol dependence: A case report.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Butorphanol; GABA Modulators; Humans; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Nitrazepam; Opiate Substitution Treatment; Opioid-Related Disorders | 2018 |
Tissue Residue Levels of the Tranquilizer Combination of Butorphanol, Azaperone, and Medetomidine, and the Antagonists, Naltrexone, Atipamezole, and Tolazoline, in Black Bears (Ursus americanus) Postimmobilization.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Antihypertensive Agents; Azaperone; Butorphanol; Drug Combinations; Drug Residues; Hypnotics and Sedatives; Imidazoles; Immobilization; Medetomidine; Naltrexone; Narcotic Antagonists; Tolazoline; Ursidae | 2020 |
Disentanglement of Cape fur seals (Arctocephalus pusillus pusillus) with reversible medetomidine-midazolam-butorphanol.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Butorphanol; Conscious Sedation; Drug Combinations; Fur Seals; Hypnotics and Sedatives; Imidazoles; Medetomidine; Midazolam; Naltrexone; Narcotic Antagonists | 2021 |